A
HRMY icon

AlphaQuest’s Harmony Biosciences HRMY Stock Holding History

AlphaQuest’s Portfolio HRMY Stock Details HRMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,718
Closed -$551K – 923
2025
Q4 		$551K Buy
14,718
+1,518
+12% +$49.9K 0.03% 753
2025
Q3 		$364K Sell
13,200
-4,401
-25% -$152K 0.02% 1018
2025
Q2 		$556K Buy
17,601
+13,603
+340% +$438K 0.05% 549
2025
Q1 		$133K Sell
3,998
-9,100
-69% -$326K 0.01% 1171
2024
Q4 		$451K Sell
13,098
-22,625
-63% -$777K 0.06% 533
2024
Q3 		$1.43M Buy
35,723
+20,689
+138% +$727K 0.13% 240
2024
Q2 		$454K Buy
15,034
+10,639
+242% +$320K 0.06% 487
2024
Q1 		$148K Buy
4,395
+4,028
+1,098% +$129K 0.03% 740
2023
Q4 		$11.9K Buy
+367
New +$10.2K ﹤0.01% 991

Other funds holding HRMY

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

AlphaQuest's HRMY Position: Q1 2026 in Review

AlphaQuest sold out of Harmony Biosciences (HRMY) in Q1 2026, closing a stake of 14,718 shares — an estimated $551K sold.

AlphaQuest first reported a position in HRMY in Q4 2023 and held it in 9 quarters. The position peaked at $1.43M in Q3 2024. 311 funds tracked by Wall St. Rank hold HRMY as of Q1 2026.

  • AlphaQuest reported no remaining Harmony Biosciences position as of Q1 2026 after selling out during the quarter.
  • AlphaQuest sold 14,718 Harmony Biosciences shares in Q1 2026, an estimated $551K.
  • AlphaQuest first reported a position in Harmony Biosciences in Q4 2023 and held it in 9 quarters.
  • AlphaQuest's Harmony Biosciences position peaked at $1.43M in Q3 2024.
  • 311 funds tracked by Wall St. Rank held Harmony Biosciences as of Q1 2026.

Based on AlphaQuest's 13F filing for Q1 2026.